Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...

A novel consent process facilitated the prospective use of real-world data to evaluate clinical changes without the delays ...

Tripp Razor highlights the disproportionately high pancreatic cancer risk among Black Americans and the systemic disparities ...

Discover what clinical trials are, why they're vital for new treatments, and how you can participate in life-changing medical ...

How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical ...

Clara was one of the first patients to undergo treatment using NeuroOne's OneRF ® platform. Since the procedure in June 2024, Clara has been completely seizure-free, which has greatly improved her ...

As the leading cause of cancer-related death, lung cancer remains a noteworthy hazard to human health. NSCLC is the most prevalent subtype, accounting ...

| AI solutions in clinical trials are only as good as the data they process. With a focus on quality, AI can be harnessed to ...

There is excitement and hope in the insulin market the world over after U.S. based pharma giant Eli Lilly & Company on Monday ...

Newsweek's AI Impact Award winners share how they measure success and guarantee outcomes: setting themselves apart in a ...

South Carolina is creating a statewide network for researching and treating Alzheimer's disease even as advocates lobby for ...

MP0726, a Radio-DARPin candidate targeting mesothelin (MSLN) and intended for the treatment of ovarian cancer, is nominated for development under strategic partnership with Orano Med The oral ...